H

HealthCare Ventures LLC

12 employees

HealthCare Ventures is a life science venture capital firm that invests in early clinical stage companies which transform patient care.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology59
Health Care47
Medical23
Pharmaceutical21
Medical Device10
Health Diagnostics10
Therapeutics8
Genetics5
Pain Management and Women's Health4
immunotherapy4
antibody treatment4
diabetes treatment4
cancer treatment4
biotechnology4
autoimmune disease4
Life Science4
Women's3
Beauty3
beauty3
Pharmaceuticals2

Funding rounds participated in

$21M sweet spot round size

Most of their 84 investments are in rounds between $11M and $34M

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

1985

Investments made

C

Colorescience raised $30M on September 14, 2020

Investors: K2 HealthVentures and HealthCare Ventures LLC

L

Leap Therapeutics raised undisclosed on January 1, 2016

Investors: HealthCare Ventures LLC

P

Proteostasis Therapeutics, Inc. (PTI) raised $37M on September 8, 2015

Investors: Sanofi Ventures, F-Prime Capital Partners and HealthCare Ventures LLC

G

Galleon Pharmaceuticals raised $10M on June 11, 2015

Investors: Morgenthaler, TPG Global, BioAdvance and HealthCare Ventures LLC

V

Vaxxas raised $25M on February 10, 2015

Investors: HealthCare Ventures LLC

C

Colorescience raised $15M on September 10, 2014

Investors: Longwood Fund, Split Rock Partners, Domain Associates and HealthCare Ventures LLC

S

Senseonics, Inc. raised $20M on June 5, 2014

Investors: Anthem Capital, Greenspring Associates, Rho Ventures, Abingworth and HealthCare Ventures LLC

P

Pathogenetix, Inc. raised $10M on October 30, 2013

Investors: Ascension Ventures, Excel Venture Management, LLC and HealthCare Ventures LLC

U

Undisclosed raised $5.1M on April 1, 2013

Investors: Morgenthaler, - and HealthCare Ventures LLC

U

Undisclosed raised $3M on October 15, 2012

Investors: Shire Pharmaceuticals, Morgenthaler, Forbion, Easton Capital Investment Group, Polaris Partners and HealthCare Ventures LLC

FAQ